The global structural heart market is experiencing remarkable expansion due to the increasing prevalence of cardiovascular disorders, rapid technological advancements, and the growing adoption of minimally invasive procedures. Structural heart devices are transforming the treatment landscape for patients suffering from heart valve diseases, congenital heart defects, and other cardiac abnormalities. Rising awareness regarding early diagnosis and improved treatment outcomes is further contributing to market growth across developed and emerging economies.

The structural heart market size is projected to reach US$ 28.48 billion by 2031 from US$ 14.25 billion in 2023. The market is expected to register a CAGR of 8.00% during 2023–2031.

Increasing Burden of Cardiovascular Diseases Driving Market Expansion

Cardiovascular diseases remain one of the leading causes of mortality worldwide, significantly increasing the demand for advanced structural heart therapies. Conditions such as aortic stenosis, mitral regurgitation, and congenital heart defects are becoming increasingly common among the aging population. As a result, healthcare providers are rapidly adopting innovative structural heart devices to improve patient outcomes and reduce surgical complications.

The growing geriatric population is a major factor supporting market development. Older individuals are more susceptible to structural heart disorders, creating strong demand for transcatheter procedures and heart valve replacement technologies. In addition, lifestyle-related risk factors such as obesity, hypertension, smoking, and diabetes are contributing to the increasing incidence of heart-related conditions globally.

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPHE100001164

Technological Advancements Accelerating Adoption

Continuous innovation in cardiac treatment technologies is playing a crucial role in the growth of the structural heart industry. Manufacturers are investing heavily in research and development to introduce safer, more effective, and minimally invasive solutions. Transcatheter heart valve replacement procedures have gained significant popularity due to shorter recovery times, reduced hospital stays, and lower procedural risks compared to conventional open-heart surgeries.

Advanced imaging technologies, robotic-assisted procedures, and improved catheter-based devices are also enhancing procedural accuracy and treatment success rates. These innovations are enabling physicians to treat complex heart conditions more efficiently while improving patient comfort and long-term outcomes.

Growing Preference for Minimally Invasive Procedures

The increasing preference for minimally invasive cardiovascular procedures is one of the strongest trends influencing the market. Patients and healthcare professionals are increasingly opting for transcatheter therapies because they reduce trauma, minimize complications, and support faster recovery.

Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair procedures are witnessing widespread acceptance across hospitals and cardiac centers. The demand for these procedures is expected to increase substantially as healthcare infrastructure continues to improve and physicians gain greater expertise in minimally invasive cardiac interventions.

Additionally, shorter hospitalization periods associated with these procedures help reduce overall healthcare costs, making them more attractive for healthcare systems worldwide.

Expanding Healthcare Infrastructure in Emerging Economies

Emerging economies are presenting significant growth opportunities for structural heart device manufacturers. Countries across Asia Pacific, Latin America, and the Middle East are investing heavily in healthcare modernization, advanced cardiac care facilities, and specialized treatment centers.

Improved access to healthcare services, rising healthcare expenditure, and increasing awareness regarding advanced treatment options are contributing to market growth in these regions. Governments and private healthcare organizations are also supporting the adoption of innovative cardiac technologies to address the growing burden of cardiovascular diseases.

The expansion of medical tourism in developing nations is further creating favorable conditions for market players, particularly in regions offering cost-effective cardiac treatments with advanced medical expertise.

Key Segments Supporting Market Growth

The structural heart market is witnessing strong demand across multiple product categories, including heart valve devices, occluders, annuloplasty rings, and delivery systems. Among these, transcatheter heart valves continue to dominate due to rising adoption rates and technological advancements.

Hospitals remain the leading end users owing to the increasing number of cardiac procedures performed globally. Specialized cardiac centers are also contributing significantly to market expansion by offering advanced minimally invasive structural heart treatments.

Furthermore, increasing clinical trials and regulatory approvals for next-generation structural heart devices are expected to enhance product availability and accelerate market penetration during the forecast period.

Competitive Landscape and Strategic Developments

Leading companies in the industry are focusing on strategic collaborations, acquisitions, and product launches to strengthen their market presence. Market participants are emphasizing innovation and expanding their product portfolios to address the growing demand for advanced cardiac therapies.

Top Players in the Structural Heart Market

• Abbott Laboratories
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Medtronic plc
• LivaNova PLC
• CryoLife Inc.
• Lepu Medical Technology
• JenaValve Technology Inc.
• Venus Medtech
• Biotronik

These companies are actively investing in advanced transcatheter technologies and expanding their global distribution networks to enhance market competitiveness.

Regional Insights and Growth Opportunities

North America continues to hold a significant share of the structural heart industry due to advanced healthcare infrastructure, strong reimbursement systems, and increasing adoption of innovative cardiac technologies. The region also benefits from a high prevalence of cardiovascular diseases and strong presence of leading market players.

Europe is also witnessing steady growth supported by rising demand for minimally invasive procedures and favorable government initiatives for cardiovascular care.

Meanwhile, Asia Pacific is expected to emerge as one of the fastest-growing regions during the forecast period. Rapid urbanization, growing healthcare investments, and increasing awareness regarding advanced heart treatments are driving demand across countries such as China, India, and Japan.

Future Outlook of the Structural Heart Market

The future outlook for the structural heart market remains highly promising as technological advancements continue to reshape cardiovascular treatment approaches. Increasing acceptance of minimally invasive therapies, combined with rising investments in healthcare innovation, is expected to create substantial growth opportunities through 2031.

Artificial intelligence integration, improved imaging systems, and next-generation transcatheter devices are anticipated to enhance procedural precision and patient outcomes further. Additionally, expanding clinical research activities and favorable regulatory support are likely to accelerate the commercialization of advanced structural heart therapies.

As healthcare providers increasingly prioritize patient-centric and minimally invasive treatment solutions, the demand for structural heart devices is expected to maintain strong momentum over the coming years.

Top Trending Reports @

Health Self-Monitoring Technologies Market

ICU Equipment Market

Transcutaneous Oxygen Monitor Market

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish